10.1038/ng0396-266 102 PaaszA.CzekajP
After 12 months, the tesamorelin group experienced: A greater reduction in hepatic-fat fraction than the placebo group An approximately 37% relative reduction in liver fat from baseline A higher proportion of participants whose hepatic-fat fraction fell below the studys threshold for steatosis The study also examined liver enzymes and fibrosis-related outcomes
The most pronounced effects occur acutely upon treatment initiation and wane over the course of the first 90 days of exposure
Health Conditions A-Z Health & Wellness Nutrition Fitness Health News Ayurveda Videos Medicine A-Z Parenting Login to get the latest articles, videos, gallery, and a lot more or continue with Email Google Facebook To get Registered Signup now Credit: iStock Rachel V Thomas Updated Jul 16, 2026 | 10:18 AM IST Summary The study found that the GLP-1 drugs yielded benefits beyond weight loss, including reducing binge eating, loss of control eating and emotional eating
i tng ph hp: Ngi t 18 tui tr ln, c bit l ngi c ln da xn mu, nm, tn nhang, hoc cn ci thin sc khe t bn trong